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Introduction
The spleen is the largest collection of lymphoid
tissue in the body. It has important haematological
and immunological functions and may be involved in
malignant disease. CT offers a simple, rapid way to assess
the spleen in patients with cancer and here we review CT
of splenic disease in such cases.
CT
The spleen on non-enhanced CT is homogeneous and
has an attenuation of 35-55HU, that is 5-10HU less than
that of liver. The spleen is optimally evaluated with the
use of intravenous contrast material. The spleen normally
demonstrates heterogeneous enhancement immediately
after bolus injection of contrast material. Only after a
minute or more does the splenic parenchyma achieve
uniform homogeneous enhancement. This is thought to
reflect the variable blood flow within different compart-
ments of the spleen and should not be misinterpreted for
pathology.
The shape and position of the normal spleen can vary
considerably. The radiologist also needs to be aware that
a number of normal variants and congenital anomalies
affect the spleen. Residual clefts between adjacent
lobulations may mimic lacerations and prominent lobes
may mimic splenic mass lesions. Ectopic splenic tissue
of congenital origin gives rise to accessory spleen. In
autopsy series accessory spleens are present in 10–30%
of the population. They are usually solitary and occur
near the splenic hilum (75%), but may be found elsewhere
in the abdomen. Accessory spleen varies in size from
a few millimetres to several centimetres in diameter.
After splenectomy, an accessory spleen can hypertrophy
dramatically causing recurrence of problems in patients
who have undergone splenectomy for hypersplenism. The
typical accessory spleen has a smooth, round or ovoid
shape and its blood supply is usually derived from the
splenic artery with drainage into the splenic vein.
The normal adult spleen size measures approximately
12–15 cm in length, 4–8 cm in antero-posterior diameter
and 3–4 cm in thickness. However the irregular shape and
oblique orientation of the spleen means that these linear
measurements are of limited use. Furthermore, splenic
volume varies greatly from one individual to another.
Normal in vivo adult splenic volume ranges from 107
to 314 cm3. A quick quantitative assessment of splenic
size can be made on imaging on CT using splenic index,
i.e. the product of the length, width and thickness. The
normal splenic index is between 120–480 cm3.
Splenomegaly
There are many causes of splenomegaly, and it may
occasionally be related to neoplastic disorders such
as lymphoma, leukaemia, primary benign or malignant
tumours and metastases. A clue to the underlying cause
can sometimes be identified on imaging, e.g. abdominal
lymph node enlargement may suggest lymphoma.
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Benign mass lesion
Splenic cystic lesions may be due to cystic neoplasm
(lymphangioma or haemangioma), cystic metastasis or
abscess (haematoma or pseudocyst). Non-neoplastic
splenic cysts are true (primary) cysts, which possess
a cellular lining or false (secondary) cyst which have
no cellular lining. True cysts are either parasitic
(echinococcal) or non-parasitic (i.e. epithelial also called
epidermoid, mesothelial, or primary cyst). Epithelial
cysts are congenital in origin while false cysts, i.e.
pseudocysts are post traumatic in origin and thought to
represent the final stage in the evolution of a splenic
haematoma.
On CT, splenic cysts are well defined, of water density
or signal, and show no enhancement after intravenous
contrast. It is usually difficult to distinguish between true
and false cysts on imaging, but certain characteristics
may be useful in differentiating between them. CT
demonstrates cyst wall calcification in 14% of true
cysts and 50% of false cysts. Cyst wall trabeculation or
peripheral septation occurs in 86% of true cysts and 17%
of false cysts. High attenuation cysts may occur in up to
one third of false cysts.
Haemangioma is the most common primary benign
neoplasm of the spleen occurring in 0.03% to 14% of
cases at autopsy. Most lesions are detected incidentally
but in large haemangioma splenic rupture and anaemia,
thrombocytopenia and coagulopathy (Kasabach–Merritt
syndrome) has been reported. Splenic haemangiomas can
be multiple and a part of a generalised angiomatosis as
in Klippel–Trenauny–Weber syndrome. On CT, haeman-
giomas may appear either solid and/or cystic and may
enhance in a similar pattern to hepatic haemangioma.
Some lesions are relatively avascular or show slow filling
of contrast material.
Lymphangioma can occur as single or multiple lesions
and are usually asymptomatic and are categorised as
capillary, cavernous or cystic depending on size of the
abnormal lymphatic channels. In the spleen the cystic
type is most common. CT shows multiple thin walled,
well-marginated cysts often subcapsular in location. No
enhancement is seen and the attenuation measurements
vary from 15-35HU.
Splenic hamartomas (also called splenomas, or nodular
hyperplasia of the spleen) are rare benign lesions
composed of an anomalous mixture of normal splenic
elements with red pulp predominating. The hamartoma
occur singly or less commonly as mutiple nodules. On
CT, they appear iso or hypodense on the precontrast
images, with the occasional lesion showing cystic
component.
Splenic malignancy
Splenic lymphoma is the most common splenic
malignancy and is usually a manifestation of generalised
lymphoma. It is estimated that at the time of diagnosis,
splenic involvement is present in 25–35% of patients with
lymphoma. In patients with NHL, splenic involvement
is associated with para-aortic nodal involvement in
approximately 70% of patients. On imaging, splenic
involvement in lymphoma can take several forms:
(1) homogeneous enlargement; (2) miliary nodules;
(3) multifocal 1 to 10 cm lesions; (4) single solitary mass.
In the majority of patients, the involvement is diffuse and
difficult to identify on CT because splenomegaly does not
necessarily indicate involvement. One third of patients
have splenomegaly without infiltration; conversely one
third of normal-sized spleen are found to have tumour
following splenectomy. Necrosis of large lesion can give
rise to an irregular cystic lesion. Radiologically visible
calcification has been reported in aggressive lesions and
after chemotherapy.
Primary splenic lymphoma, which is usually of the
non-Hodgkin’s type, is rare and comprises 1–2% of
all lymphoma. Other primary tumours of the spleen
are very rare and include angiosarcoma, fibrosarcoma,
leiomyosarcoma, malignant teratoma and malignant
fibrous histocytoma. Splenic angiosarcoma is very rare
but is the most common non-lymphoid primary malignant
tumour of the spleen. The prognosis is very poor (20%
surviving months). About 70% of all angiosarcoma
metastasise to the liver and approximately 30% undergo
spontaneous rupture. Imaging reveals an enlarged spleen
with a poorly defined mass and there may be areas of
haemorrhage within it.
Metastatic disease
Metastatic deposits in the spleen are unusual, comprising
4–7% of patients with metastases in multiple organs. The
most common primary sites for splenic metastases are
the breast, lung and melanoma. Splenic metastases most
frequently appear as multiple nodules. On CT, nodular
metastases appear as rounded hypodense lesions. Cystic
lesions may occur with metastases from ovary, breast,
endometrium and melanoma. Calcification is uncommon
but occurs in patients with mucinous adenocarcinoma
primary. Peritoneal implants in patients with ovarian, GI
or pancreatic cancer can cause scalloping of the splenic
capsular surface.
Miscellaneous spleen lesions in
oncology patients
Splenic infection may arise as a consequence of
immunosuppression from chemotherapy especially fun-
gal infection. The most common pathogens are Candida
and Aspergillus. Fungal infection in the spleen is most
likely to appear as a miliary or multifocal process.
Splenic infarcts may occur from mass lesion com-
pressing splenic vasculature, e.g. pancreatic tumours.
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Splenic infarction may be diffuse or focal. On CT,
infarcts typically appear as sharply marginated, low-
density wedge-shaped areas. Occasionally the infarct
may be multiple, resulting in poorly defined hypodense
lesions. When the entire spleen is infarcted only rim
enhancement of the capsule occurs from capsular vessels.
Key points
(1) The early heterogeneous enhancement in the
spleen should not be misinterpreted for pathology
(2) The commonest splenic malignancy is lymphoma.
The spleen is involved as a part of the generalised
lymphoma. An enlarged spleen is not a reliable
indicator of lymphomatous involvement.
(3) Metastases to the spleen are very uncommon.
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